Collagen, Type I, alpha 1 (COL1A1) Peptide
Quick Overview for Collagen, Type I, alpha 1 (COL1A1) Peptide (ABIN938780)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- GLGRQVYDPK YCAAPTEPVI HNGSQGTGTN GSEISDSDYQ AEYPDEYHGE
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of COL1 A1 antibody,
Alternative Names: COL1A1 control peptide, COL1A1 antibody Blocking Peptide, Anti-COL1A1 Blocking Peptide, collagen, type I, alpha 1 Blocking Peptide, OI4 Blocking Peptide, COL1A1, COLA-1, COLA 1, COLA-1 Blocking Peptide, COLA 1 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- COL1A1 (Collagen, Type I, alpha 1 (COL1A1))
-
Background
- This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor.
-
Molecular Weight
- 36 kDa
Target
-